Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.
de Bono DP, Simoons ML, Tijssen J, Arnold AE, Betriu A, Burgersdijk C, López Bescos L, Mueller E, Pfisterer M, Van de Werf F, et al. de Bono DP, et al. Among authors: van de werf f. Br Heart J. 1992 Feb;67(2):122-8. doi: 10.1136/hrt.67.2.122. Br Heart J. 1992. PMID: 1540431 Free PMC article. Clinical Trial.
Evaluation of the effect of thrombolytic treatment on infarct size and left ventricular function by enzymatic, scintigraphic, and angiographic methods. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator.
Mortelmans L, Vanhaecke J, Lesaffre E, Arnold A, Urbain JL, Hermens W, De Roo M, De Geest H, Verstraete M, Van de Werf F. Mortelmans L, et al. Among authors: de roo m, de geest h, van de werf f. Am Heart J. 1990 Jun;119(6):1231-7. doi: 10.1016/s0002-8703(05)80169-3. Am Heart J. 1990. PMID: 2112877 Clinical Trial.
Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.
Willems JL, Willems RJ, Willems GM, Arnold AE, Van de Werf F, Verstraete M. Willems JL, et al. Among authors: van de werf f. Circulation. 1990 Oct;82(4):1147-58. doi: 10.1161/01.cir.82.4.1147. Circulation. 1990. PMID: 2119263 Clinical Trial.
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Roe MT, et al. Among authors: van de werf f. Eur Heart J. 2004 Feb;25(4):313-21. doi: 10.1016/j.ehj.2003.12.009. Eur Heart J. 2004. PMID: 14984920 Free article. Clinical Trial.
759 results